We are live on ! Find out more
ABEOW

Abeona Therapeutics Inc Warrant

Delisted

ABEOW was delisted on the 20th of December, 2019.

4 hedge funds and large institutions have $2.06M invested in Abeona Therapeutics Inc Warrant in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% less funds holding

Funds holding: 54 (-1)

73% less capital invested

Capital invested by funds: $7.49M → $2.06M (-$5.44M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
OFG
OTA Financial Group
New York
-$360K
2
UBS Group
UBS Group
Switzerland
-$1.35K
Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$1.27M
HCM
2
Highbridge Capital Management
New York
$788K
UBS Group
3
UBS Group
Switzerland
$2K -$1.35K -295 -35%
OFG
4
OTA Financial Group
New York
-$360K -35,426 Closed

ABEOW Hedge Fund Activity: Q4 2018 in Review

4 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q4 2018, worth a combined $2.06M — down 73% from $7.49M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ABEOW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was OTA Financial Group, exiting entirely with an estimated $360K sold.

  • 4 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q4 2018, down from 5 in Q3 2018.
  • Funds reported $2.06M of Abeona Therapeutics Inc Warrant stock for Q4 2018, down 73% quarter-over-quarter.
  • 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q4 2018 and 1 closed out, a net change of -1 holder.
  • The largest Abeona Therapeutics Inc Warrant seller in Q4 2018 was OTA Financial Group, an estimated $360K sold.

Based on aggregated 13F filings for Q4 2018.